Terasaki Innovation Summit to focus on improving technological, entrepreneurial translation of personalized medicines
The Terasaki Institute for Biomedical Innovation (TIBI) will be hosting the Terasaki Innovation Summit on March 8-10, 2023, at the…
Beyond vaccines: emerging technologies capable of unlocking the promise of biologically targeted mRNA therapeutics
Researchers reviewed technology advancements that will unlock the promise of biologically targeted messenger ribonucleic acid (mRNA) therapeutics beyond vaccines.
Scientists illuminate the molecular events underlying childhood movement disorder
Scientists at the UNC School of Medicine and UNC Eshelman School of Pharmacy, in collaboration with a team from Queen…
New Pathogen Analyzer combines the advantages of PCR and rapid antigen testing
Speed or accuracy? As far as COVID-19 tests go, this was the choice you had to make. In the future,…
Microplastics are associated with the biological risks of water-borne viral transmission
Microplastics are not just tiny particles that can be ingested, they can also carry viruses, a University of Queensland study…
Novel troponin test may help improve the treatment of heart attack patients
A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac…
New insights on antibody responses to omicron variants
Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is…
SpikImm announces the clinical trials start for SPK001, its monoclonal antibody against SARS-Cov-2
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered…
Association of COVID-19 severity with nasopharyngeal fungal colonization and interleukin-17 induction
Researchers evaluated the concurrent colonization of fungi in the nasopharynx of severe COVID-19 patients.
RNA-sensing platform could help detect and selectively kill tumors, or edit the genome in specific cells
Researchers at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT have developed…